Evidence map›Paper›PMID 35762580›Full record

ArticleCNS neuroscience & therapeutics2022

Hypoxia-induced polypoid giant cancer cells in glioma promote the transformation of tumor-associated macrophages to a tumor-supportive phenotype.

Yuyang Liu, Ying Shi, Mengwan Wu, Jialin Liu, Hong Wu, Chuan Xu, Ling Chen

Open access · goldAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Polyploidy and mTOR signaling: a possible molecular link.Cell communication and signaling : CCS · 2024
    Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yuyang LiuMedical School of Chinese PLA, Beijing, China.ORCID 0000-0003-0128-5039
Ying ShiSchool of Medicine, University of Electronic science and Technology of China, Chengdu, China.
Mengwan WuSchool of Medicine, University of Electronic science and Technology of China, Chengdu, China.
Jialin LiuDepartment of Neurosurgery, Chinese PLA General Hospital, Beijing, China.ORCID 0000-0001-6625-3076
Hong WuIntegrative Cancer Center& Cancer Clinical Research Center, Sichuan Cancer Hospital, Chengdu, China.
Chuan XuIntegrative Cancer Center& Cancer Clinical Research Center, Sichuan Cancer Hospital, Chengdu, China.ORCID 0000-0002-5320-2277
Ling ChenDepartment of Neurosurgery, Chinese PLA General Hospital, Beijing, China.
Chinese PLA General Hospital · CNSichuan Cancer Hospital · CNUniversity of Electronic Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsPolypoid giant cancer cells (PGCCs) represent a unique subgroup of stem-like cells, acting as a critical factor in promoting the recurrence of various solid tumors. The effect of PGCCs on the tumor malignancy of glioma and its immune microenvironment remains unclear.

methodsBioinformatic analysis was performed to investigate the relationship between M2 tumor-associated macrophages (TAMs) infiltration and survival of glioblastoma (GBM) patients. The spatial location of M2 TAMs in GBM was also investigated using the Ivy Glioblastoma Atlas Project (Ivy GAP) database. PGCCs were quantified in glioma of different grades. CoCl

resultsThe magnitude of M2 TAMs infiltration is significantly correlated with poor survival in GBM patients. M2 TAMs were enriched in the perinecrotic zone (PNZ) of GBM and positively correlated with hypoxic levels. Increased PGCCs were detected in glioma specimens of higher grades. CoCl

conclusionsPGCCs promote malignancy and immune-suppressive microenvironment in GBM. PGCCs or their progeny cells may be a potential therapeutic target for GBM.

Indexed as

GlioblastomaGliomaCell Line, TumorHumansHypoxiaMacrophagesPhenotypeTumor-Associated MacrophagesTumor Microenvironmentgliomahypoxiapolypoid giant cancer celltumor-associated macrophages

Identifiers

PMID35762580
PMCPMC9344088
OpenAlexW4283659345

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.